10-Q Filing

ENZON PHARMACEUTICALS, INC. CIK: 727510 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001144204-12-060778`
Period End Date	20120930
Filing Date	20121109
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	enzn-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 66 Income Statement 108 Cash Flow Statement 56

Balance Sheet 66 line items

Line Item	Tag	Value	Unit	Period
Property and equipment, net of accumulated depreciation.	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$40.57M	USD	Point-in-time
Property and equipment, net of accumulated depreciation.	`AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment`	$43.99M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$305.00M	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Preferred stock, par value (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$140.95M	USD	Point-in-time
Marketable securities - available-for-sale	`MarketableSecuritiesCurrent`	$137.49M	USD	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	3.00M	shares	Point-in-time
Marketable securities - available-for-sale	`MarketableSecuritiesCurrent`	$58.19M	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.75M	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$2.24M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$280.67M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$165.26M	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	0.00	shares	Point-in-time
Property and equipment, net of accumulated depreciation of $43,992 at September 30, 2012 and $40,573 at December 31, 2011	`PropertyPlantAndEquipmentNet`	$16.80M	USD	Point-in-time
Property and equipment, net of accumulated depreciation of $43,992 at September 30, 2012 and $40,573 at December 31, 2011	`PropertyPlantAndEquipmentNet`	$13.32M	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Common stock, par value (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.01	USD	Point-in-time
Marketable securities - available-for-sale	`MarketableSecuritiesNoncurrent`	$160.78M	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	170.00M	shares	Point-in-time
Marketable securities - available-for-sale	`MarketableSecuritiesNoncurrent`	$10.30M	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	45.21M	shares	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$367.00K	USD	Point-in-time
Other assets	`OtherAssetsNoncurrent`	$172.00K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	48.29M	shares	Point-in-time
Total assets	`Assets`	$304.47M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	45.21M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	48.29M	shares	Point-in-time
Total assets	`Assets`	$343.21M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.57M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.06M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$13.69M	USD	Point-in-time
Accrued expenses and other current liabilities	`AccruedLiabilitiesCurrent`	$7.39M	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	-	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$115.85M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.26M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$124.30M	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	-	USD	Point-in-time
Notes payable	`LongTermNotesPayable`	$129.50M	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$452.00K	USD	Point-in-time
Other liabilities	`OtherLiabilitiesNoncurrent`	$1.26M	USD	Point-in-time
Total liabilities	`Liabilities`	$124.75M	USD	Point-in-time
Total liabilities	`Liabilities`	$146.03M	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock - $.01 par value, authorized 3,000,000 shares; no shares issued and outstanding at September 30, 2012 and December 31, 2011	`PreferredStockValue`	-	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 45,207,688 shares at September 30, 2012 and 48,292,702 shares at December 31, 2011	`CommonStockValue`	$452.00K	USD	Point-in-time
Common stock - $.01 par value, authorized 170,000,000 shares; issued and outstanding 45,207,688 shares at September 30, 2012 and 48,292,702 shares at December 31, 2011	`CommonStockValue`	$483.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$341.76M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapitalCommonStock`	$321.84M	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$3.00K	USD	Point-in-time
Accumulated other comprehensive income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$113.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-142.69M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-145.06M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$179.72M	USD	Point-in-time
Total stockholders' equity	`StockholdersEquity`	$197.18M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$304.47M	USD	Point-in-time
Total liabilities and stockholders' equity	`LiabilitiesAndStockholdersEquity`	$343.21M	USD	Point-in-time

Income Statement 108 line items

Line Item	Tag	Value	Unit	Period
Royalties	`RoyaltyRevenue`	$31.14M	USD	3 Qtrs
Royalties	`RoyaltyRevenue`	$10.92M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$10.21M	USD	1 Quarter
Royalties	`RoyaltyRevenue`	$31.01M	USD	3 Qtrs
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	-	USD	1 Quarter
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	-	USD	3 Qtrs
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	-	USD	1 Quarter
Sale of in-process research and development	`SaleOfInProcessResearchAndDevelopment`	$5.00M	USD	3 Qtrs
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$54.00K	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	-	USD	1 Quarter
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$1.38M	USD	3 Qtrs
Contract research and development	`ResearchAndDevelopmentArrangementContractToPerformForOthersCompensationEarned`	$136.00K	USD	3 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$541.00K	USD	3 Qtrs
Miscellaneous income	`OtherSalesRevenueNet`	$202.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$179.00K	USD	1 Quarter
Miscellaneous income	`OtherSalesRevenueNet`	$806.00K	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$38.06M	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$31.95M	USD	3 Qtrs
Total revenues	`SalesRevenueNet`	$10.44M	USD	1 Quarter
Total revenues	`SalesRevenueNet`	$11.12M	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$3.95M	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$31.05M	USD	3 Qtrs
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$10.44M	USD	1 Quarter
Research and development - pipeline	`ResearchAndDevelopmentExpense`	$16.54M	USD	3 Qtrs
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$123.00K	USD	3 Qtrs
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$878.00K	USD	3 Qtrs
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$47.00K	USD	1 Quarter
Research and development - specialty and contracted services	`ResearchAndDevelopmentArrangementContractToPerformForOthersCostsIncurredGross`	$10.00K	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$13.81M	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$11.24M	USD	3 Qtrs
General and administrative	`OtherGeneralAndAdministrativeExpense`	$3.21M	USD	1 Quarter
General and administrative	`OtherGeneralAndAdministrativeExpense`	$4.10M	USD	1 Quarter
General and administrative - contracted services	`GeneralAndAdministrativeExpenseContractedServices`	-	USD	1 Quarter
General and administrative - contracted services	`GeneralAndAdministrativeExpenseContractedServices`	$2.00K	USD	1 Quarter
General and administrative - contracted services	`GeneralAndAdministrativeExpenseContractedServices`	$114.00K	USD	3 Qtrs
General and administrative - contracted services	`GeneralAndAdministrativeExpenseContractedServices`	-	USD	3 Qtrs
Restructuring charges	`RestructuringCharges`	$-113.00K	USD	1 Quarter
Restructuring charges	`RestructuringCharges`	$4.65M	USD	3 Qtrs
Restructuring charges	`RestructuringCharges`	$-220.00K	USD	3 Qtrs
Restructuring charges	`RestructuringCharges`	$3.62M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$50.50M	USD	3 Qtrs
Total operating expenses	`OperatingExpenses`	$7.06M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$18.20M	USD	1 Quarter
Total operating expenses	`OperatingExpenses`	$27.69M	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$4.27M	USD	3 Qtrs
Operating income (loss)	`OperatingIncomeLoss`	$4.06M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-7.76M	USD	1 Quarter
Operating income (loss)	`OperatingIncomeLoss`	$-12.44M	USD	3 Qtrs
Investment income, net	`InvestmentIncomeNet`	$2.39M	USD	3 Qtrs
Investment income, net	`InvestmentIncomeNet`	$1.39M	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$407.00K	USD	1 Quarter
Investment income, net	`InvestmentIncomeNet`	$1.25M	USD	3 Qtrs
Interest expense	`InterestExpense`	$4.44M	USD	3 Qtrs
Interest expense	`InterestExpense`	$1.48M	USD	1 Quarter
Interest expense	`InterestExpense`	$1.27M	USD	1 Quarter
Interest expense	`InterestExpense`	$4.05M	USD	3 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$-191.00K	USD	3 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$2.00K	USD	1 Quarter
Other, net	`OtherNonoperatingIncomeExpense`	$90.00K	USD	3 Qtrs
Other, net	`OtherNonoperatingIncomeExpense`	$-69.00K	USD	1 Quarter
Total other income (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-1.14M	USD	1 Quarter
Total other income (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-1.86M	USD	3 Qtrs
Total other income (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$-3.10M	USD	3 Qtrs
Total other income (expense)	`NonOperatingIncomeExpenseIncludingInterestExpense`	$114.00K	USD	1 Quarter
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-15.54M	USD	3 Qtrs
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$2.41M	USD	3 Qtrs
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$4.17M	USD	1 Quarter
Income (loss) before income tax expense	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest`	$-8.90M	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$33.00K	USD	3 Qtrs
Income tax expense	`IncomeTaxExpenseBenefit`	-	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$200.00K	USD	1 Quarter
Income tax expense	`IncomeTaxExpenseBenefit`	$205.00K	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$4.17M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-15.74M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-9.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.38M	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.30	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.05	USD	3 Qtrs
Basic (in dollars per share)	`EarningsPerShareBasic`	$-0.19	USD	1 Quarter
Basic (in dollars per share)	`EarningsPerShareBasic`	$0.09	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.30	USD	3 Qtrs
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$-0.19	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.08	USD	1 Quarter
Diluted (in dollars per share)	`EarningsPerShareDiluted`	$0.05	USD	3 Qtrs
Weighted-average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	46.39M	shares	1 Quarter
Weighted-average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	47.61M	shares	3 Qtrs
Weighted-average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	48.73M	shares	1 Quarter
Weighted-average shares outstanding - basic (in shares)	`WeightedAverageNumberOfSharesOutstandingBasic`	53.13M	shares	3 Qtrs
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	58.56M	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	48.73M	shares	1 Quarter
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	47.67M	shares	3 Qtrs
Weighted-average shares outstanding - diluted (in shares)	`WeightedAverageNumberOfDilutedSharesOutstanding`	53.13M	shares	3 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$1.07M	USD	3 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-601.00K	USD	3 Qtrs
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-323.00K	USD	1 Quarter
Unrealized holding gains (losses) arising during period	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$590.00K	USD	1 Quarter
Reclassification adjustment for realized gains on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-979.00K	USD	1 Quarter
Reclassification adjustment for realized gains on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-960.00K	USD	3 Qtrs
Reclassification adjustment for realized gains on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-139.00K	USD	1 Quarter
Reclassification adjustment for realized gains on sales included in net income (loss)	`OtherComprehensiveIncomeLossReclassificationAdjustmentForSaleOfSecuritiesIncludedInNetIncomeNetOfTax`	$-219.00K	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-462.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-389.00K	USD	1 Quarter
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$110.00K	USD	3 Qtrs
Total other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-820.00K	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-9.57M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$3.79M	USD	1 Quarter
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$-16.56M	USD	3 Qtrs
Comprehensive income (loss)	`ComprehensiveIncomeNetOfTax`	$2.48M	USD	3 Qtrs

Cash Flow Statement 56 line items

Line Item	Tag	Value	Unit	Period
Net income (loss)	`NetIncomeLoss`	$4.17M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$-15.74M	USD	3 Qtrs
Net income (loss)	`NetIncomeLoss`	$-9.11M	USD	1 Quarter
Net income (loss)	`NetIncomeLoss`	$2.38M	USD	3 Qtrs
Depreciation	`DepreciationAndAmortization`	$4.00M	USD	3 Qtrs
Depreciation	`DepreciationAndAmortization`	$3.50M	USD	3 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$425.00K	USD	3 Qtrs
Amortization and write-off of debt issuance costs	`AmortizationOfFinancingCosts`	$404.00K	USD	3 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$2.73M	USD	3 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$600.00K	USD	1 Quarter
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$1.55M	USD	3 Qtrs
Stock-based compensation and employee purchase plan discount	`ShareBasedCompensation`	$700.00K	USD	1 Quarter
(Gains) on sales of marketable securities	`MarketableSecuritiesGainLoss`	$-960.00K	USD	3 Qtrs
(Gains) on sales of marketable securities	`MarketableSecuritiesGainLoss`	$-219.00K	USD	3 Qtrs
Losses on early retirement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	-	USD	3 Qtrs
Losses on early retirement of notes payable	`GainsLossesOnExtinguishmentOfDebt`	$212.00K	USD	3 Qtrs
Amortization of purchase premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$2.35M	USD	3 Qtrs
Amortization of purchase premium on marketable securities	`AccretionAmortizationOfDiscountsAndPremiumsInvestments`	$971.00K	USD	3 Qtrs
Other	`OtherNoncashIncomeExpense`	$-8.00K	USD	3 Qtrs
Other	`OtherNoncashIncomeExpense`	$61.00K	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-7.38M	USD	3 Qtrs
Changes in operating assets and liabilities	`IncreaseDecreaseInOperatingCapital`	$-905.00K	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$2.06M	USD	3 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-8.70M	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$557.00K	USD	3 Qtrs
Purchases of property and equipment	`PaymentsToAcquirePropertyPlantAndEquipment`	$23.00K	USD	3 Qtrs
Proceeds from sales of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$9.00K	USD	3 Qtrs
Proceeds from sales of fixed assets	`ProceedsFromSaleOfPropertyPlantAndEquipment`	$4.00K	USD	3 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$265.31M	USD	3 Qtrs
Proceeds from sales and maturities of marketable securities	`ProceedsFromSaleAndMaturityOfMarketableSecurities`	$34.07M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$195.41M	USD	3 Qtrs
Purchases of marketable securities	`PaymentsToAcquireMarketableSecurities`	$1.07M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$69.89M	USD	3 Qtrs
Net cash provided by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$32.45M	USD	3 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$21.44M	USD	3 Qtrs
Repurchases of common stock	`PaymentsForRepurchaseOfCommonStock`	$120.79M	USD	3 Qtrs
Repurchases of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	$-13.86M	USD	3 Qtrs
Repurchases of notes payable	`ProceedsFromRepaymentsOfNotesPayable`	-	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$5.67M	USD	3 Qtrs
Proceeds from issuance of common stock	`ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions`	$62.00K	USD	3 Qtrs
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$1.16M	USD	3 Qtrs
Withholding taxes - stock-based compensation	`PaymentsRelatedToTaxWithholdingForShareBasedCompensation`	$102.00K	USD	3 Qtrs
Proceeds from employee stock purchase plan, net	`ProceedsFromStockPlans`	$1.00K	USD	3 Qtrs
Proceeds from employee stock purchase plan, net	`ProceedsFromStockPlans`	$15.00K	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-35.33M	USD	3 Qtrs
Net cash used in financing activities	`NetCashProvidedByUsedInFinancingActivities`	$-116.28M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$36.62M	USD	3 Qtrs
Net increase (decrease) in cash and cash equivalents	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-92.53M	USD	3 Qtrs
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$305.00M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashAndCashEquivalentsAtCarryingValue`	$140.95M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$104.32M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$305.00M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$397.53M	USD	Point-in-time
Cash and cash equivalents at end of period	`CashAndCashEquivalentsAtCarryingValue`	$140.95M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.